Impact of progressive aortic regurgitation on outcomes after left ventricular assist device implantation
Authors:
- Hrvoje GasparovicHGHrvoje Gasparovic
- Nina JakusNJNina Jakus
- Jasper J. BrugtsJBJasper J. Brugts
- Anne-Catherine PouleurAPAnne-Catherine Pouleur
- Philippe TimmermansPTPhilippe Timmermans
- Pawel RubiśPawel Rubiś
- Edvinas GaizauskasEGEdvinas Gaizauskas
- Emeline M. Van CraenenbroeckECEmeline M. Van Craenenbroeck
- Eduardo Barge-CaballeroEBEduardo Barge-Caballero
- Sebastian GrundmannSGSebastian Grundmann
- Stefania PaolilloSPStefania Paolillo
- 23 June 2022
- journal article
- research article
- Published by Springer Nature in Heart and Vessels
- Vol. 37 (12) , 1985-1994
Abstract
Aortic regurgitation (AR) following continuous flow left ventricular assist device implantation (cf-LVAD) may adversely impact outcomes. We aimed to assess the incidence and impact of progressive AR after cf-LVAD on prognosis, biomarkers, functional capacity and echocardiographic findings. In an analysis of the PCHF-VAD database encompassing 12 European heart failure centers, patients were dichotomized according to the progression of AR following LVAD implantation. Patients with de-novo AR or AR progression (AR_1) were compared to patients without worsening AR (AR_0). Among 396 patients (mean age 53 ± 12 years, 82% male), 153 (39%) experienced progression of AR over a median of 1.4 years on LVAD support. Before LVAD implantation, AR_1 patients were less frequently diabetic, had lower body mass indices and higher baseline NT-proBNP values. Progressive AR did not adversely impact mortality (26% in both groups, HR 0.91 [95% CI 0.61–1.36]; P = 0.65). No intergroup variability was observed in NT-proBNP values and 6-minute walk test results at index hospitalization discharge and at 6-month follow-up. However, AR_1 patients were more likely to remain in NYHA class III and had worse right ventricular function at 6-month follow-up. Lack of aortic valve opening was related to de-novo or worsening AR (P < 0.001), irrespective of systolic blood pressure (P = 0.67). Patients commonly experience de-novo or worsening AR when exposed to continuous flow of contemporary LVADs. While reducing effective forward flow, worsening AR did not influence survival. However, less complete functional recovery and worse RV performance among AR_1 patients were observed. Lack of aortic valve opening was associated with progressive AR.Keywords
This publication has 19 references indexed in Scilit:
- The burden of haemocompatibility with left ventricular assist systems: a complex weaveEuropean Heart Journal, 2017
- LVAD Outflow Graft Angle and Thrombosis RiskASAIO Journal, 2017
- Prevalence of De Novo Aortic Valve Insufficiency in Patients After HeartWare VAD Implantation with an Intermittent Low-Speed AlgorithmASAIO Journal, 2016
- Accurate Quantification Methods for Aortic Insufficiency Severity in Patients With LVADJACC: Cardiovascular Imaging, 2016
- Development of de novo aortic valve incompetence in patients with the continuous-flow HeartWare ventricular assist deviceThe Journal of Heart and Lung Transplantation, 2016
- Prevalence, Significance, and Management of Aortic Insufficiency in Continuous Flow Left Ventricular Assist Device RecipientsCirculation: Heart Failure, 2014
- Analysis of aortic valve commissural fusion after support with continuous-flow left ventricular assist deviceInteractive CardioVascular and Thoracic Surgery, 2013
- The Development of Aortic Insufficiency in Left Ventricular Assist Device-Supported PatientsCirculation: Heart Failure, 2010
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and doppler echocardiographyJournal of the American Society of Echocardiography, 2003